ActoBiotics®

ActoBiotics®
Product Description

Intrexon Corporation offers a wide range of technologies which includes ActoBiotics®. Feature: it is a new class of orally delivered biopharmaceuticals. Through our proprietary platform, food-grade microbes (Lactococcus lactis) are engineered to generate biologically contained ActoBiotics® therapeutics for in situ expression and secretion of novel proteins and peptides including cytokines, enzymes, hormones, and monoclonal antibodies within the body. The ActoBiotics® platform offers the unique ability to deliver biological effectors selectively to the oral and gastrointestinal tract enabling treatment opportunities not achievable through customary mechanisms like injectable medicines and permitting ease of administration for patients. With intervention focused at the site of pathology, this groundbreaking class of orally available biopharmaceuticals has the potential to facilitate targeted therapies against oral, gastrointestinal, metabolic, allergic and autoimmune diseases. Contact us for more information.

Intrexon Corporation

  • US
  • 2016
    On CPHI since
Company types
Contract Service
Specifications
  • Selling Points
    Quality Service
  • Supplied from
    United States

Intrexon Corporation

  • US
  • 2016
    On CPHI since
Company types
Contract Service

More Products from Intrexon Corporation (2)

  • AttSite™ Recombinases

    Product AttSite™ Recombinases

    Intrexon Corporation offers a wide range of technologies which includes AttSite™ Recombinases. Feature: it enable targeted gene delivery at a specific location in the host cell genome opening the door to functional genomics and development of high-expressing production cell lines for therapeutic proteins. ...
  • BeyondBio™

    Product BeyondBio™

    Intrexon Corporation offers a wide range of technologies which includes BeyondBio™. Feature: it is designed to combine the principles of precision engineering, statistical modeling, automation, and lean production to power the next generation of optimized biological designs for unique DNA-based solutions a...